The National Community Pharmacists Association (NCPA) has expressed its support for the reintroduction of the Pharmacists Fight Back Act, a bill aimed at reforming pharmacy benefit manager (PBM) practices. Read More »

Anthony M. DiGiorgio, DO, MHA, an assistant professor of neurosurgery at the University of California, San Francisco (UCSF), expressed concerns about the 340B program during an appearance on the Healthcare Unfiltered podcast. Read More »

The North Carolina Department of Health and Human Services (NC DHHS) has revised its regulations concerning the return and disposal of controlled substances from long-term care facilities. Read More »

Legislation aimed at increasing oversight of pharmacy benefit managers (PBMs) was introduced in the U.S. Senate, with support from both parties. Read More »

The National Community Pharmacists Association (NCPA) has announced a series of upcoming events aimed at supporting pharmacists and pharmacy teams throughout December and into early 2026. Read More »

Heath Veuleman, a Healthcare Strategist for Seersucker Strategies, has expressed concerns about various hospital cost centers, including 340B profits, facility fees, provider taxes, and higher site-based Medicare payments. Read More »

DC Health has released its 2025 Perinatal Health and Infant Mortality Report, which covers data from 2019 to 2023 and details trends in maternal and infant health in Washington, DC. Read More »

Molly Jenkins, Senior Director of Public Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), said that the 340B program is increasing Medicare costs by blocking rebates and worsening taxpayer burdens. Read More »

Mayor Muriel Bowser will officially open the new Fort Totten–Takoma segment of the Metropolitan Branch Trail (MBT) on Wednesday, November 12 at 11 a.m. The event will take place at the intersection of Whittier Street NW and Blair Road NW, near... Read More »

The National Community Pharmacists Association (NCPA), Pharmacy Technician Certification Board (PTCB), and Professional Compounding Centers of America (PCCA) have announced the launch of Compounding PATH for Technicians, a new program designed to... Read More »

South Dakota is marking National Rural Health Day on November 20, 2025, following a proclamation by Governor Larry Rhoden. Read More »

The National Community Pharmacists Association (NCPA), the Pharmacy Technician Certification Board (PTCB), and PCCA have announced the launch of Compounding PATH for Technicians, a new program aimed at raising national training standards for... Read More »

Ryan Long, Director and Senior Research Fellow at Paragon Health Institute, expressed concerns about the 340B Drug Pricing Program's impact on wealthier hospitals, costs, and safety-net providers. Read More »

Lori M. Reilly, Chief Operating Officer for the Pharmaceutical Research and Manufacturers of America (PhRMA), said that the 340B program is increasing taxpayer costs without demonstrated patient benefits and requires accountability and reform. Read More »

The South Dakota Department of Health has reported positive outcomes from its Bright Start Nurse Home Visiting Program, which provides support to first-time pregnant women in selected counties across the state. Read More »

Mayor Muriel Bowser led a dual event in Ward 8, marking the opening of the new DC Animal Shelter at DC Village and the groundbreaking for the DC Fire and Emergency Medical Services (FEMS) and Office of the State Superintendent of Education (OSSE)... Read More »

The Georgia Board of Pharmacy has announced that its administrative offices will not be open for in-person visits on Monday, November 10 and Tuesday, November 11. Read More »

Jennifer Riley, Executive Director of Patients Come First, expressed concerns about deceptive legal advertisements concerning FDA-approved medicines. Read More »

Sally Pipes, President and CEO of the Pacific Research Institute, expressed concerns regarding the 340B Drug Pricing Program, highlighting how government initiatives can be subject to corruption and misuse despite their intended purpose. Read More »

The Institute for Clinical and Economic Review (ICER) has released a white paper detailing strategies to enhance the affordability of GLP-1 obesity drugs, including the improvement of patent-quality review processes. Read More »